Hitomi Hosoya

1.3k citations
24 papers · 238 indexed · h-index 9
Topics
CAR-T cell therapy research (7 papers)Multiple Myeloma Research and Treatments (6 papers)Cancer Genomics and Diagnostics (3 papers)
Partner nations
United StatesJapanItaly

In The Last Decade

Hitomi Hosoya

20 papers receiving 233 citations

Peers

Hitomi Hosoya
Comparison fields: 5 of 59
  • Oncology 90
  • Molecular Biology 69
  • Hematology 45
  • Immunology 36
  • Biomedical Engineering 32
Replace Laura Zamurs with:
Laura Zamurs Australia
Irene Arroyo‐Solera Spain
Araci M. R. Rondon Netherlands
Claudia Lange Germany
Karoline Lipnik Austria
Laura R. Pageon United States
M. J. Crossley United Kingdom
Mira Tulla Finland
Angela R. Blissett United States
Jessie Brown United States
Hitomi Hosoya relative to Laura Zamurs Australia Laura Zamurs's profile →
Citations per field
00.5×3.6×
Laura Zamurs · 1×
Citations per year

Countries citing papers authored by Hitomi Hosoya

Since Specialization
Citations

This map shows the geographic impact of Hitomi Hosoya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Hosoya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Hosoya more than expected).

Fields of papers citing papers by Hitomi Hosoya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Hosoya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Hosoya. The network helps show where Hitomi Hosoya may publish in the future.

Co-authorship network of co-authors of Hitomi Hosoya

This figure shows the co-authorship network connecting the top 25 collaborators of Hitomi Hosoya. A scholar is included among the top collaborators of Hitomi Hosoya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitomi Hosoya. Hitomi Hosoya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 2
5 3
6 7
7 0
8 2
9 1
10 8
11 1
12 20
13 3
14 12
15 24
16 8
17 35
18 34
19 36
20 32

About Hitomi Hosoya

Hitomi Hosoya is a scholar working on Hematology, Oncology and Genetics, having authored 24 papers that have together received 238 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Hematology (45 citations), Oncology (90 citations) and Genetics (31 citations). Hitomi Hosoya has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Richard L. Sidman, Renata Pasqualini, Wadih Arap, Eleonora Dondossola, Angelo Corti, Robert A. Somer, Chris T. Derk, E. Magda Barbu, Surbhi Sidana and Roberto Rangel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026